All reports
Pharmaceutical
Rare and Orphan Diseases
mRNA Platforms Beyond Vaccines: Rare Disease and Oncology
Code: NSC/PHRM/0014Published Apr 22, 2026
About this report
Moderna, BioNTech, CureVac: mRNA pipeline in personalized oncology and rare therapies.
Humans at the core of the analysis
Partner specialist firms, independent domain experts and our in-house analyst team: every report is written and reviewed by humans who cross-check signals, verify sources and prioritise what matters.
Key insights
Request the sample to discover the report's key insights.
Table of contents
The detailed table of contents is shared with the free sample.